Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17

This study has been terminated.

( Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns. )

Study NCT00754052 Information provided by Eisai Inc.

First Received: September 15, 2008 Last Updated: December 10, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	April 2009
Estimated Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)